Work to distribute the experimental Covid-19 vaccine developed by Pfizer Inc and BioNTech SE is gearing up after the companies announced successful interim data earlier on Monday, but it will not be coming to local pharmacies for the general public any time soon.

The data, which sent US stocks to record highs, showed that the two companies’ experimental vaccine is 90% effective at preventing Covid-19. They are still awaiting data on safety, which could come later this month.